Baxter Healthcare Recalls Spectrum IQ Infusion Pumps Due to Missing Safety Testing
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Baxter Healthcare Corporation has voluntarily recalled five Spectrum IQ Infusion Pumps in Ohio after discovering the units were distributed without required occlusion alarm testing.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references Ohio, United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevice.
What Happened
Baxter Healthcare Corporation has initiated a voluntary Class II recall of specific Spectrum IQ Infusion Pumps. The recall was triggered because these units were released into distribution without undergoing full safety testing, specifically missing the required occlusion alarm testing. This failure to test means the devices may not properly alert healthcare providers if an infusion line becomes blocked.
Which Products Are Affected
This recall is limited to five (5) units distributed in the state of Ohio. The affected products are identified by the following details:
- Brand Name: Spectrum IQ
- Product Name: Infusion Pump
- Model/Catalog Number: 3570009
- GTIN: 00085412610900
- Serial Numbers: 3815663, 3823468, 3824743, 3825234, and 3825599
- Recall Number: Z-1368-2026
What You Should Do
Healthcare facilities and providers in Ohio should immediately check their inventory for the serial numbers listed above. Baxter Healthcare Corporation initiated the notification process via telephone. Owners of the affected devices should contact the firm at 1 Baxter Pkwy, Deerfield, IL 60015, to arrange for the return or proper testing of the units.
Why This Matters
Occlusion alarms are critical safety features that ensure patients receive the correct dosage of medication without interruption. If a pump fails to detect a blockage, it could lead to a delay in treatment or the delivery of an incorrect dose, posing a serious risk to patient health.
Source
Information provided by the FDA. Recall Event ID: 98306.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.